ED
EGO icon

Exane Derivatives’s Eldorado Gold EGO Stock Holding History

Exane Derivatives’s Portfolio EGO Stock Details EGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$269K Buy
42,175
+41,999
+23,863% +$382K 0.15% 136
2022
Q1 		$1.97K Hold
176
– – ﹤0.01% 752
2021
Q4 		$1.65K Sell
176
-41,754
-100% -$386K ﹤0.01% 675
2021
Q3 		$324K Buy
41,930
+2,663
+7% +$23.6K 0.08% 265
2021
Q2 		$383K Buy
39,267
+3,695
+10% +$41.1K 0.09% 238
2021
Q1 		$384K Buy
35,572
+5,391
+18% +$63.7K 0.11% 184
2020
Q4 		$401K Buy
30,181
+831
+3% +$10.7K 0.12% 198
2020
Q3 		$310K Buy
29,350
+2,245
+8% +$25.2K 0.09% 172
2020
Q2 		$263K Sell
27,105
-48,245
-64% -$419K 0.07% 200
2020
Q1 		$465K Sell
75,350
-6,629
-8% -$49.9K 0.13% 130
2019
Q4 		$607K Buy
81,979
+17,798
+28% +$138K 0.11% 149
2019
Q3 		$499K Buy
64,181
+140
+0.2% +$1.14K 0.09% 164
2019
Q2 		$373K Sell
64,041
-27,907
-30% -$118K 0.07% 201
2019
Q1 		$426K Buy
+91,948
New +$358K 0.08% 163
2018
Q4 		– Sell
-90,716
Closed -$392K – 696
2018
Q3 		$392K Sell
90,716
-459
-0.5% -$2.26K 0.07% 178
2018
Q2 		$451K Sell
91,175
-338
-0.4% -$1.74K 0.08% 190
2018
Q1 		$376K Buy
91,513
+14,884
+19% +$87.2K 0.08% 177
2017
Q4 		$550K Buy
76,629
+76,594
+218,840% +$569K 0.09% 156
2017
Q3 		$387 Hold
35
– – ﹤0.01% 478
2017
Q2 		$465 Hold
35
– – ﹤0.01% 500
2017
Q1 		$600 Hold
35
– – ﹤0.01% 426
2016
Q4 		$567 Hold
35
– – ﹤0.01% 486
2016
Q3 		$692 Hold
35
– – ﹤0.01% 486
2016
Q2 		$792 Hold
35
– – ﹤0.01% 427
2016
Q1 		$556 Hold
35
– – ﹤0.01% 485
2015
Q4 		$523 Hold
35
– – ﹤0.01% 419
2015
Q3 		$567 Hold
35
– – ﹤0.01% 447
2015
Q2 		$729 Hold
35
– – ﹤0.01% 451
2015
Q1 		$808 Sell
35
-6,742
-99% -$185K ﹤0.01% 451
2014
Q4 		$206K Buy
+6,777
New +$220K 0.03% 211

Other funds holding EGO

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $212M AUM 153.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CC
Carrhae Capital London, United Kingdom $3.62B AUM 34.35% 1-Year Est. Return

Exane Derivatives's EGO Position: Q2 2022 in Review

Exane Derivatives increased its Eldorado Gold (EGO) stake by 23,863% in Q2 2022, buying an estimated $382K and bringing the position to 42,175 shares worth $269K. The position accounts for 0.15% of the portfolio, ranked #136.

Exane Derivatives first reported a position in EGO in Q4 2014 and has held it in 30 quarters since. The position peaked at $607K in Q4 2019. 136 funds tracked by Wall St. Rank hold EGO as of Q2 2022.

  • Exane Derivatives held 42,175 shares of Eldorado Gold worth $269K as of Q2 2022.
  • Exane Derivatives bought 41,999 Eldorado Gold shares in Q2 2022, an estimated $382K.
  • Eldorado Gold made up 0.15% of Exane Derivatives's portfolio in Q2 2022, its #136 holding.
  • Exane Derivatives first reported a position in Eldorado Gold in Q4 2014 and has held it in 30 quarters since.
  • Exane Derivatives's Eldorado Gold position peaked at $607K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Eldorado Gold as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.